Identification of an EML4-ALK rearrangement in an intrahepatic cholangiocarcinoma

Pathol Int. 2021 Sep;71(9):630-632. doi: 10.1111/pin.13138. Epub 2021 Jul 7.

Authors

Loëtitia Favre^{1

2

3}, Anaïs Pujals^{1

2

3}, Pascale Maille¹, Elsa Poullot¹, Julien Calderaro^{1

2

4}

Affiliations

¹ Department of Pathology, University Hospital Henri Mondor, AP-HP, Créteil, France.
² Faculty of Medicine, University of Paris-Est Créteil (UPEC), Créteil, France.
³ IMRB, Inserm U955, Team 9, Faculty of Medicine, University of Paris-Est Créteil (UPEC), Créteil, France.
⁴ IMRB, Inserm U955, Team 18, Faculty of Medicine, University of Paris-Est Créteil (UPEC), Créteil, France.

PMID: 34231939
DOI: 10.1111/pin.13138

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Cholangiocarcinoma / diagnosis
Cholangiocarcinoma / genetics*
Cholangiocarcinoma / pathology
Cholangiocarcinoma / surgery
Gene Rearrangement*
Hepatectomy
Humans
In Situ Hybridization, Fluorescence
Liver / pathology
Liver / surgery
Liver Neoplasms / diagnosis
Liver Neoplasms / genetics*
Liver Neoplasms / pathology
Liver Neoplasms / surgery
Male
Oncogene Proteins, Fusion / genetics*

Substances

EML4-ALK fusion protein, human
Oncogene Proteins, Fusion